Complete financial analysis of Aurora Cannabis Inc. (ACB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aurora Cannabis Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Cambium Global Timberland Limited (TREE.L) Income Statement Analysis – Financial Results
- Pertama Digital Berhad (8532.KL) Income Statement Analysis – Financial Results
- CHOTHANI FOODS LIMITED (CHOTHANI.BO) Income Statement Analysis – Financial Results
- Federal Agricultural Mortgage Corporation (AGM) Income Statement Analysis – Financial Results
- N-able, Inc. (NABL) Income Statement Analysis – Financial Results
Aurora Cannabis Inc. (ACB)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.auroramj.com
About Aurora Cannabis Inc.
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 270.28M | 233.29M | 221.34M | 245.25M | 278.91M | 247.94M | 55.20M | 18.07M | 1.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.83K | 0.00 | 0.00 |
| Cost of Revenue | 138.82M | 297.65M | 200.11M | 266.81M | 312.45M | 88.12M | 11.68M | 2.01M | 763.00K | 304.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 131.46M | -64.36M | 21.23M | -21.56M | -33.54M | 159.82M | 43.52M | 16.06M | 676.27K | -304.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.83K | 0.00 | 0.00 |
| Gross Profit Ratio | 48.64% | -27.59% | 9.59% | -8.79% | -12.03% | 64.46% | 78.84% | 88.87% | 46.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 3.57M | 6.56M | 10.39M | 11.45M | 26.07M | 14.78M | 1.68M | 314.00K | 565.14K | 432.38K | 307.93K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 104.94M | 68.22M | 126.97M | 139.68M | 265.18M | 279.40M | 80.42M | 14.40M | 3.93M | 2.61M | 280.67K | 152.64K | 250.02K | 181.96K | 49.99K | 185.35K | 0.00 | 0.00 |
| Selling & Marketing | 51.94M | 51.97M | 62.03M | 55.20M | 91.27M | 99.29M | 29.45M | 10.27M | 1.71M | 1.02M | 248.21K | 142.94K | 61.27K | 18.97K | 7.20K | 0.00 | 0.00 | 0.00 |
| SG&A | 156.88M | 183.40M | 188.99M | 194.88M | 356.45M | 378.69M | 109.86M | 24.67M | 5.63M | 3.63M | 280.67K | 295.59K | 311.29K | 200.93K | 57.18K | 185.35K | 228.56K | 1.25K |
| Other Expenses | 1.67M | 0.00 | -21.59M | 6.13M | -28.64M | -3.26M | -907.00K | -1.14M | 593.22K | -5.06M | 25.82K | 107.29K | 19.50K | 409.00 | 583.00 | 834.00 | 490.00 | 0.00 |
| Operating Expenses | 158.54M | 189.96M | 240.60M | 225.09M | 450.93M | 456.84M | 123.63M | 25.70M | 6.79M | 4.37M | 306.49K | 402.88K | 330.79K | 201.33K | 57.77K | 186.18K | 229.05K | 1.25K |
| Cost & Expenses | 297.36M | 487.61M | 440.71M | 491.90M | 763.38M | 544.97M | 135.30M | 27.71M | 6.03M | 4.37M | 306.49K | 402.88K | 330.79K | 201.33K | 57.77K | 186.18K | 229.05K | 1.25K |
| Interest Income | 12.81M | 19.00M | 4.51M | 5.75M | 4.99M | 3.68M | 2.51M | 861.00K | 72.78K | 27.64K | 7.86K | 9.39K | 15.03K | 15.56K | 14.35K | 40.83K | 0.00 | 0.00 |
| Interest Expense | 14.19M | 39.46M | 71.81M | 66.44M | 77.54M | 41.03M | 2.28M | 1.29M | 619.12K | 177.41K | 101.08K | 9.39K | 15.03K | 745.00 | 484.00 | 310.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 33.07M | 43.57M | 93.66M | 98.08M | 114.89M | 88.26M | 12.26M | 1.09M | 593.22K | 304.80K | 303.00 | 432.00 | 422.00 | 409.00 | 583.00 | 834.00 | 490.00 | 0.00 |
| EBITDA | 20.47M | -210.74M | -143.09M | -137.20M | -393.23M | -214.66M | -78.46M | -12.98M | -4.75M | -9.24M | -298.33K | -402.45K | -330.36K | -185.36K | -57.18K | -144.52K | -228.56K | -1.25K |
| EBITDA Ratio | 7.58% | -90.34% | -64.65% | -55.94% | -140.99% | -86.58% | -142.14% | -71.86% | -329.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -353.91% | 0.00% | 0.00% |
| Operating Income | -46.45M | -254.32M | -231.45M | -282.82M | -490.96M | -314.24M | -95.77M | -11.19M | -4.59M | -4.37M | -306.49K | -402.88K | -330.79K | -202.08K | -58.25K | -145.35K | -229.05K | -1.25K |
| Operating Income Ratio | -17.19% | -109.01% | -104.57% | -115.32% | -176.03% | -126.74% | -173.51% | -61.95% | -318.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -355.95% | 0.00% | 0.00% |
| Total Other Income/Expenses | -31.15M | -41.10M | -1.43B | -392.46M | -2.83B | 6.14M | 168.08M | -1.90M | 89.08K | -5.06M | -93.22K | 9.39K | 15.03K | -167.26K | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -59.60M | -295.42M | -1.72B | -699.80M | -3.38B | -328.23M | 77.33M | -17.26M | -5.87M | -9.73M | -399.71K | -393.49K | -315.76K | -353.77K | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -22.05% | -126.63% | -777.14% | -285.34% | -1,213.27% | -132.38% | 140.09% | -95.56% | -408.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -554.00K | -20.32M | -2.14M | -6.32M | -83.40M | -30.31M | 8.10M | -4.30M | -148.84K | -207.71K | 7.86K | 0.00 | 0.00 | -31.28K | -13.86K | 310.00 | -51.76K | -1.27K |
| Net Income | -69.33M | -265.33M | -1.72B | -693.63M | -3.31B | -290.84M | 71.94M | -12.97M | -5.72M | -9.52M | -399.71K | -393.49K | -315.76K | -322.50K | -43.91K | -145.66K | -177.29K | 1.27K |
| Net Income Ratio | -25.65% | -113.73% | -776.02% | -282.82% | -1,186.90% | -117.30% | 130.33% | -71.78% | -397.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -356.71% | 0.00% | 0.00% |
| EPS | -1.46 | -8.22 | -7.99 | -41.01 | -342.14 | -435.59 | 1.88 | -0.56 | -0.53 | -1.48 | -0.30 | -0.29 | -0.24 | -0.24 | -0.04 | -0.12 | -0.19 | 0.01 |
| EPS Diluted | -1.46 | -8.22 | -7.99 | -41.01 | -342.14 | -435.59 | 1.83 | -0.56 | -0.53 | -1.48 | -0.30 | -0.29 | -0.24 | -0.24 | -0.04 | -0.12 | -0.19 | 0.01 |
| Weighted Avg Shares Out | 47.42M | 32.27M | 214.91M | 16.91M | 9.68M | 667.69K | 38.32M | 23.25M | 10.75M | 6.41M | 1.35M | 1.34M | 1.32M | 1.32M | 1.23M | 1.20M | 935.16K | 162.85K |
| Weighted Avg Shares Out (Dil) | 47.42M | 32.27M | 214.91M | 16.91M | 9.68M | 667.69K | 39.28M | 23.25M | 10.75M | 6.41M | 1.35M | 1.34M | 1.32M | 1.32M | 1.23M | 1.20M | 935.16K | 162.85K |
Could the Biden Administration's Latest Move Send Aurora Cannabis Stock Soaring?
Shares of Aurora Cannabis skyrocketed briefly on hopes of marijuana reform taking place in the U.S. The pot stock is popular in the cannabis industry, and it's also extremely volatile. The company hopes to achieve positive free cash flow this...
This Is How Marijuana Stocks Will Be Impacted By Reform In 2024
As the cannabis industry continues its growth in 2024, a confluence of regulatory, demographic, and market trends is shaping the sector. This has presented a fertile ground for savvy investors. Here's a deeper look into the evolving landscape of cannabis...
The 3 Best Cannabis Stocks to Buy in May 2024
Cannabis stocks are back in the spotlight and moving higher on news that the U.S. government is moving to reclassify the recreational drug and ease federal restrictions imposed on it. The Biden administration has taken steps to reclassify cannabis, also...
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Among the emerging industries that have captured the attention of investors is the cannabis sector. The cannabis industry has experienced remarkable growth, giving rise to a new breed of top cannabis stocks to buy for investments in May.
Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company Launches Prem ium Products Redefining Patient Care EDMONTON, AB , May 8, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) the Canadian based leading global medical cannabis company, is proud to announce...
Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling
The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.
Cannabis Stocks: Game-Changing Catalyst for the Sector?
Cannabis stocks reignited Tuesday afternoon after the U.S. Department of Justice announced that it would move to reclassify marijuana as a less dangerous drug. As a result of the breaking news, several leading cannabis stocks, like Tilray NASDAQ: TLRY, Aurora Cannabis...
Stock Market Crash Warning: Don't Get Caught Holding These 3 Cannabis Stocks
For cannabis stock investors, April ended in absolute euphoria. The sector has skyrocketed this week.
Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally
Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday. That rally came about after reports claimed the Biden Administration is moving forward with plans to reschedule cannabis...
Aurora Cannabis (ACB) Moves 46.0% Higher: Will This Strength Last?
Aurora Cannabis (ACB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Source: https://incomestatements.info
Category: Stock Reports